Search Within

Danny Nejad Khalil

Formats
  1. Meeting Abstract (32)
  2. Journal Article (26)
  3. Review (6)
Groups
  1. Department of Medicine (64)
  2. Gastrointestinal Oncology Service (64)
  3. Solid Tumor Oncology Division (64)
  4. Weinberg Fellows (64)
  5. Center for Pancreatic Cancer Research (34)
  6. Epidemiology and Biostatistics (27)

More Groups

People
  1. Ghassan Abou-Alfa (26)
  2. James Harding (24)
  3. Eileen O'Reilly (20)
  4. Imane El Dika (18)
  5. Marinela Capanu (15)
  6. Wungki Park (14)

More People

Years
  1. 2025 (4)
  2. 2024 (6)
  3. 2023 (10)
  4. 2022 (13)
  5. 2021 (4)
  6. 2020 (6)

More Years

Publications
  1. Journal of Clinical Oncology (17)
  2. Journal for ImmunoTherapy of Cancer (8)
  3. Clinical Cancer Research (5)
  4. Annals of Oncology (4)
  5. Cancer Research (3)
  6. Cancer (2)

More Publications

Publishers
  1. American Society of Clinical Oncology (18)
  2. Biomed Central Ltd (9)
  3. American Association for Cancer Research (8)
  4. Oxford University Press (6)
  5. MDPI (3)
  6. Wiley Blackwell (3)

More Publishers

Results (64)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Exploratory platform trial to evaluate immunotherapy combinations with chemotherapy for the treatment of patients with previously untreated metastatic pancreatic adenocarcinoma (REVOLUTION)
    Meeting Abstract

    Lyman, J.; O'Reilly, E.; Wainberg, Z.; Fisher, G.; Wolff, R.; Ko, A.; O'Hara, M.; Singh, H.; Amaravadi, R.; Kimmelman, A.; more...
    Journal for ImmunoTherapy of Cancer (2022)

    Fulltext@MSK | Save
  • Results from a phase 1 study of CDX-1140, a fully human anti-CD40 agonist monoclonal antibody (mAb), in combination with pembrolizumab
    Meeting Abstract

    Sanborn, R.; Gabrail, N.; Carneiro, B.; O'Hara, M.; Bordoni, R.; Gordon, M.; Khalil, D.; Hauke, R.; Taglienti, C.; Rogalski, M.; more...
    Journal for ImmunoTherapy of Cancer (2022)

    Fulltext@MSK | Save
  • Characterization of the tumor microbiome in patients with locally advanced rectal cancer treated with neoadjuvant therapy
    Meeting Abstract

    Vanderbilt, C. M.; Chatila, W. K.; Khalil, D. N.; Chen, C. T.; Kim, J. K.; Wu, F.; Schultz, N.; Weiser, M. R.; Garcia-Aguilar, J.; Sanchez-Vega, F.
    Cancer Research (2022)

    Fulltext@MSK | Save
  • Genomic and transcriptomic determinants of response to neoadjuvant therapy in rectal cancer
    Journal Article

    Chatila, W. K.; Kim, J. K.; Walch, H.; Marco, M. R.; Chen, C. T.; Wu, F.; Omer, D. M.; Khalil, D. N.; Ganesh, K.; Qu, X.; more...
    Nature Medicine (2022)

    Fulltext@MSK | Save
  • Tremelimumab and durvalumab in the treatment of unresectable, advanced hepatocellular carcinoma
    Review

    de Castria, T. B.; Khalil, D. N.; Harding, J. J.; O'Reilly, E. M.; Abou-Alfa, G. K.
    Future Oncology (2022)

    Fulltext@MSK | Save
  • Characterizing the clinico-genomic landscape and outcomes of KRAS G12C mutated pancreas cancer
    Meeting Abstract

    Keane, F.; Park, W.; Varghese, A.; Balogun, F.; Yu, K.; El Dika, I.; Khalil, D.; Kelsen, D. P.; Reidy-Lagunes, D.; Ku, G. Y.; more...
    Annals of Oncology (2022)

    Fulltext@MSK | Save
  • FORTITUDE: Results of a phase 1a study of the novel transgene-armed and tumor-selective vector NG-350A with and without pembrolizumab (pembro)
    Meeting Abstract

    Rosen, L. S.; Camidge, D. R.; Khalil, D.; Lillie, T.; Carter, J.; Krige, D.; Davies, J.; Miles, D.; Patel, M.; Evilevitch, V.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Immunogenomic characterization of biliary tract cancers: Biomarker enrichment for benefit to immune checkpoint blockade
    Meeting Abstract

    Park, W.; Keane, F.; Bandlamudi, C.; Donoghue, M.; de Lara, P. T.; Harding, J. J.; Khalil, D.; McKinnell, Z.; Sterpi, M.; Cao, W.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Next-generation sequencing (NGS) of circulating cell-free DNA (cfDNA) in patients (pts) with advanced hepatocellular carcinoma (HCC)
    Meeting Abstract

    Cowzer, D.; White, J. B.; Chen, P. J.; Kim, T. H.; Khalil, D.; El Dika, I. H.; Chou, J. F.; Yaqubie, A.; Light, J. S.; Shia, J.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Stereotactic ablative radiation for pancreatic cancer on a 1.5 Telsa magnetic resonance-linac system
    Journal Article

    Tringale, K. R.; Tyagi, N.; Reyngold, M.; Romesser, P. B.; Wu, A.; O'Reilly, E. M.; Varghese, A. M.; Godoy Scripes, P.; Khalil, D. N.; Park, W.; more...
    Physics and Imaging in Radiation Oncology (2022)

    Fulltext@MSK | Save